Adrian Senderowicz's Net Worth

$1.82 Million

Estimate Recalculated Sep 8, 2024 07:26PM EST

Who is Adrian Senderowicz?

Adrian Senderowicz has an estimated net worth of $1.82 Million. This is based on reported shares across multiple companies, which include CONSTELLATION PHARMACEUTICALS INC, Ignyta, Inc., PUMA BIOTECHNOLOGY, INC., and Cerulean Pharma Inc..

SEC CIK

Adrian Senderowicz's CIK is 0001616230

Past Insider Trading and Trends

2015 was Adrian Senderowicz's most active year for acquiring shares with 6 total transactions. Adrian Senderowicz's most active month to acquire stocks was the month of May. 2019 was Adrian Senderowicz's most active year for disposing of shares, totalling 5 transactions. Adrian Senderowicz's most active month to dispose stocks was the month of May. 2019 saw Adrian Senderowicz paying a total of $150,048.32 for 139,655 shares, this is the most they've acquired in one year. In 2020 Adrian Senderowicz cashed out on 28,714 shares for a total of $568,366.41, their largest year based on trade value.

Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!

CONSTELLATION PHARMACEUTICALS INC No price found

Chief Medical Officer

Adrian Senderowicz owns 15,884 units of Common Stock. In the year 2018 Adrian Senderowicz filed a total of 7 filings.

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
—
0
$27.85
-$417,931.34
15.88K
Scheduled
May 12
Form 4
—
0
—
—
0
Feb 14
Form 4
—
0
$16.82
-$615,800.28
15.88K
Scheduled
Nov 6
Form 4
—
0
—
—
0
Mar 7
Form 4
∞
15.88K
$5.51
$87,520.84
15.88K
Dec 13
Form 4
—
0
—
—
0
Jul 19
Form 3
—
0
—
—
0
No matching records found

Ignyta, Inc. No price found

Chief Medical Officer

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
—
0
—
—
0
Jan 8
Form 4
—
0
—
—
0
Aug 11
Form 3
—
0
—
—
0
No matching records found

PUMA BIOTECHNOLOGY, INC. (PBYI) Snapshot price: $2.25

Investor

Adrian Senderowicz owns 27,000 units of COMMON STOCK which is worth $60,750.00. From 2015 to 2024 Adrian Senderowicz acquired a total of 159,851 shares in PUMA BIOTECHNOLOGY, INC., Adrian also disposed a total of 132,851 shares of PUMA BIOTECHNOLOGY, INC. equalling to $813,035.09.

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
∞
27K
—
—
27K
Jun 18
Form 4
-100.00%
-27.00K
$3.33
-$89,818.20
0
Scheduled
Jun 13
Form 4
—
0
$3.45
-$93,279.60
27K
Jun 13
Form 4
-50.78%
-27.86K
$2.63
-$73,302.76
27K
Scheduled
Jun 16
Form 4
+96.92%
27K
—
—
54.86K
Jun 14
Form 4
∞
27.86K
—
—
27.86K
Jun 15
Form 4
-100.00%
-40.99K
$11.17
-$457,756.53
0
Jun 11
Form 4
-19.61%
-10.00K
$9.89
-$98,878.00
40.99K
Jun 11
Form 4
+101.99%
25.75K
—
—
50.99K
Jun 9
Form 4
+333.61%
19.42K
—
—
25.25K
Jun 10
Form 4
∞
5.82K
—
—
5.82K
Jun 12
Form 4
—
0
—
—
0
Jun 12
Form 4
—
0
—
—
0
Nov 14
Form 4
—
0
—
—
0
Apr 14
Form 4
—
0
—
—
0
Dec 16
Form 4
—
0
—
—
0
Sep 8
Form 4
—
0
—
—
0
Aug 11
Form 3
—
0
—
—
0
No matching records found

Cerulean Pharma Inc. (DARE) Snapshot price: $3.6

SVP, Chief Medical Officer

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
—
0
—
—
0
Jan 5
Form 4
—
0
—
—
0
Aug 22
Form 4
—
0
—
—
0
Jan 5
Form 4
—
0
—
—
0
Dec 1
Form 4
—
0
—
—
0
Sep 4
Form 3
—
0
—
—
0
No matching records found